Aneurysm Risk Assessment and Management

Primary Risk Factors for Aortic Aneurysms

Hypertension is the single most critical modifiable risk factor, present in 85% of patients with ruptured aortic aneurysms and 52% of those with non-ruptured aneurysms, according to the European Heart Journal 1, 2
Atherosclerosis affects over 90% of aortic aneurysm surfaces, particularly in the infrarenal segment where lack of vasa vasorum compromises nutritional supply 1, 2
Male sex has a 2-4:1 male-to-female ratio for aortic aneurysm development 2
Smoking and hypercholesterolemia are additional risk factors, though 60% of patients have cholesterol levels <240 mg/dL 1
Blunt chest trauma accounts for 15-20% of deaths in high-speed accidents, with 95% of injuries at the aortic isthmus 1, 2

Family history dramatically increases risk, with specific thresholds determining screening necessity, such as ≥2 first-degree relatives with intracranial aneurysm or SAH, which has an 8% risk of harboring unruptured aneurysm with relative risk of 4.2 3
Siblings of affected individuals have a 4-fold increased prevalence compared to other family members 4, 5
Posterior circulation location increases rupture risk 3.5-fold compared to anterior circulation, with annual rupture rates of 2.5% for posterior circulation aneurysms <7 mm versus 0% for anterior circulation 6, 7

Marfan syndrome is associated with early-onset aortic root aneurysms at 30-50 years, according to the European Society of Cardiology 2
Loeys-Dietz syndrome is associated with aggressive thoracic aortic disease, as recommended by the American College of Cardiology 2
Bicuspid aortic valve is associated with a 20-30% risk of developing aortic root aneurysms, as stated by the American Heart Association 2
Autosomal dominant polycystic kidney disease has a 10-11.5% prevalence of aneurysms, according to the National Institute of Neurological Disorders and Stroke 3
Coarctation of the aorta has an average rupture age of 25 years, as reported by the American Academy of Pediatrics 4, 5
Type IV Ehlers-Danlos syndrome affects intracranial ICA, as noted by the National Institute of Arthritis and Musculoskeletal and Skin Diseases 4, 5
Fibromuscular dysplasia is a condition that requires screening, as recommended by the American College of Radiology 4

For patients with ≥2 first-degree relatives with intracranial aneurysm, screening with MRA every 5-7 years from age 20-80 is recommended (Class I) by the American Heart Association 3
MRA without contrast has 95% sensitivity and 89% specificity for detecting aneurysms, as stated by the American College of Radiology 3
For patients with 1 first-degree relative, screening should be considered, especially with additional risk factors, as recommended by the National Institute of Neurological Disorders and Stroke 3
For autosomal dominant polycystic kidney disease, screening every 5-7 years is cost-effective given the 10-11.5% aneurysm prevalence, according to the National Institute of Diabetes and Digestive and Kidney Diseases 3

Smoking cessation is critical as one of the strongest modifiable risk factors for both aneurysm formation and rupture, as recommended by the American Heart Association 3
Blood pressure control is essential, as reducing diastolic blood pressure by 6 mmHg produces a 42% reduction in stroke incidence, according to the American College of Cardiology 3
Avoid sympathomimetic drugs, including cocaine and phenylpropanolamine, which cause subarachnoid hemorrhage, as warned by the National Institute on Drug Abuse 3
Limit alcohol consumption, as heavy use is an independent risk factor for SAH, as reported by the National Institute on Alcohol Abuse and Alcoholism 3

Aneurysm growth on serial imaging increases annual hemorrhage rate to 18.5% versus 0.2% for stable aneurysms, according to the American Stroke Association 8
Treatment should be offered for documented enlargement (Class I) by the American Heart Association 8
Previous treatment for ruptured aneurysm confers 5.5-fold increased risk of developing new aneurysms, with 1-2% annual formation rate, as reported by the National Institute of Neurological Disorders and Stroke 3